From: Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report
Total cell counts
4.35 × 105/mL
Macrophage
8%
Neutrophils
4%
Lymphocytes
71%
Eosinophils
10%
CD4/CD8 ratio
1.29